Published by Josh White on 24th February 2026
(Sharecast News) - N4 Pharma announced the appointment of Dr David H Solomon as its chief executive on Tuesday, and unveiled plans to rebrand as Thalia Therapeutics as it pivoted towards becoming an RNA therapeutics-focused biotechnology company.
URL: http://www.digitallook.com/dl/news/story/35719545/...